Microbot Medical Inc. MBOT
0.98 USD -0.05 (-4.98%)
Regular-session close
0.80 -0.18 -18.26%
After hours · Nov 13, 7:57 PM ET
0.9521 Day range 1.05
0.94 52-week range 2.85
- YTD
- -51.07%
- 1 year
- -50.82%
News
zacks.com Microbot Medical Inc. (MBOT) Reports Q3 Loss, Misses Revenue Estimates Microbot Medical Inc. (MBOT) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.07 per share a year ago.benzinga.com Microbot Medical Receives Order From ELMNT IR For 12-Month Supply Of Liberty Devices Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY Endovascular Robotic System, today announced that ELMNT IR, a multisite outpatient interventional radiology…
benzinga.com Citizens Initiates Coverage On Microbot Medical with Market Outperform Rating, Announces Price Target of $2.5 Citizens analyst Daniel Stauder initiates coverage on Microbot Medical (NASDAQ:MBOT) with a Market Outperform rating and announces Price Target of $2.5.
benzinga.com HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and maintains $12 price target.
benzinga.com Microbot Medical Receives Several New Patent Approvals Across US, Japan, China And Canada, Further Strengthening Its Global IP Portfolio The Company now holds 44 issued patents and 49 pending patents globally. Commercialization continues to advance across both U.S. and international markets.HINGHAM, Mass., Oct. 20, 2026 (GLOBE…
benzinga.com Microbot Medical Inks Three-Year Distribution Deal With Medtechnica To Advertise, Sell LIBERTY System In Israel Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that it has signed a three-year exclusive commercial distribution…
benzinga.com B. Riley Securities Reiterates Buy on Microbot Medical, Lowers Price Target to $4 B. Riley Securities analyst Anderson Schock reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and lowers the price target from $5 to $4.
benzinga.com Microbot Medical Q2 EPS $(0.08), Inline, Sales $241.000K Miss $340.000K Estimate Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 20 percent increase over losses of $(0.10) per share from the same…
benzinga.com Microbot Medical Reports 100% Growth In Revenue, New Clients In Q2 Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, is reporting greater than 100% growth in revenue and new customers for the…
benzinga.com Microbot Medical Signs Letter With Manufacturer Sanmina To Produce Its LIBERTY Single-Use, Remotely Operated Endovascular Robotic System As momentum continues to rise in the U.S., reflected in increased accounts and usage across several states, and with the momentum building in the international markets as seen with the recent…
benzinga.com Microbot Medical Inks Agreement With Lovell Government Services To Serve Federal Healthcare Systems Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, has entered into an agreement with Lovell® Government Services to serve federal…
benzinga.com LUCID CAPITAL MARKETS Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $4 LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on Microbot Medical (NASDAQ:MBOT) with a Buy rating and announces Price Target of $4.
benzinga.com Microbot Medical Receives Israel's Marketing Clearance For Its LIBERTY System Microbot Medical Inc. (NASDAQ:MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that it has achieved a significant regulatory milestone as Israel…
benzinga.com Watching Microbot Medical; Shares See Volume To The Downside; White Diamond Research Issues Report On Co https://whitediamondresearch.com/research/we-interviewed-some-of-the-first-surgeons-to-use-microbot-medicals-liberty-endovascular-robotic-system-and-its-clear-that-it-will-be-a-commercial-failure-1-pr…
benzinga.com Microbot Medical Announces LIBERTY System Gains Clinical Validation And Early Commercial Adoption As Global Expansion Accelerates Commercial adoption of the LIBERTY System by sites that participated in the clinical trial serves as a strong validation of the value it brings to everyday practiceThe Company will attend the Annual…
benzinga.com HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and maintains $12 price target.
benzinga.com Microbot Medical Completes Limited Market Release Of Its LIBERTY Endovascular Robotic System, With Commencement Of Full Market Release In The U.S. Proceeding As Planned To date, LIBERTY has been adopted by multiple healthcare systems with dozens of hospitals in their networks, including globally recognized hospitals such as Emory Healthcare and Tampa General…
benzinga.com Microbot Medical Q4 EPS $(0.04) Beats $(0.06) Estimate Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 78.95 percent increase over losses of…
benzinga.com Emory Healthcare Announces Successful Use Of Microbot Medical's Liberty System In Robotic Peripheral Endovascular Procedures Emory interventional radiologists have now demonstrated successful use of the LIBERTY System on benign prostatic hyperplasia (BPH, commonly known as enlarged prostate), as well as liver cancer.
benzinga.com This Microbot Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Tuesday
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com Why Credo Technology Group Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket
benzinga.com Aon To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
benzinga.com Why Robinhood Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Why BP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com Why Smart Share Global Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket benzinga.com Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
benzinga.com Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
benzinga.com Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session Shares of Fisker Inc. (NYSE: FSR) rose sharply during Friday’s session after the company provided a December 2023 business update.
benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 345 companies set new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 147 stocks made new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 127 companies set new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Monday Monday's session saw 114 companies set new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 76 companies set new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 85 stocks hit new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday morning, 446 companies hit new 52-week lows.
benzinga.com 34 Stocks Moving In Friday's Mid-Day Session Gainers Blue Star Foods Corp. (NASDAQ: BSFC) shares jumped 180% to $5.32 after gaining around 9% on Thursday.
benzinga.com Mid-Morning Market Update: Markets Mostly Higher; Digital Turbine Reports Multi-Year Collaboration With Google Following the market opening Tuesday, the Dow traded up 0.48% to 36,476.04 while the NASDAQ fell 0.13% to 15,850.57. The S&P also rose, gaining 0.10% to 4,795.90.
benzinga.com Stocks That Hit 52-Week Lows On Monday
benzinga.com 94 Biggest Movers From Friday
benzinga.com Stocks Which Set New 52-Week Low Yesterday, Mon., Dec. 3, 2018
benzinga.com 41 Biggest Movers From Yesterday
benzinga.com Stocks Which Set New 52-Week Low The Prior Trading Session, Fri., Nov. 23, 2018
benzinga.com Stocks Which Set New 52-Week Low The Last Trading Session, Wed., Nov. 21, 2018
benzinga.com 50 Biggest Movers From Wednesday
benzinga.com 34 Stocks Moving In Wednesday's Mid-Day Session
benzinga.com Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018
benzinga.com Stocks Which Set New 52-Week Low Yesterday, Mon., Nov. 19, 2018
